Apply for ICSPP Support

Complete the below form to apply for ICSPP Support.

Please ensure you have all the relevant documentations to hand in order to fill in the form correctly. 

 

ICSPP Logo.png

 

Concerning possible support by the International Coalition for Safe Plasma Proteins (ICSPP) for a project (either in form of local preparation of Cryoprecipitate, pathogen-reduced "Cryo-PR", of Immunoglobulins, pathogen-reduced "IG-PR", of Contract Plasma Fractionation "CPF", of Domestic Plasma Fractionation, of any other safe plasma protein product (PPP) or of any improvement of safe supplies, the applicant and the proposed project should fulfill a certain number of selection criteria (see hereafter under 1.-5.).

 

Information about applicant
Description of planned Activities / Project
1. Continual need for safe plasma protein products (PPPs):

What has been the consumption in 2022 resp. 2021 for the different PDMPs (Plasma Derived Medicinal Products) in Pakistan: 

 

Clotting factor concentrates (CFCs, all in IU):

 

What has been the consumption in 2022 resp. 2021 for the different PDMPs (Plasma Derived Medicinal Products) in the province / region deserved by applicant institute: 

 

Clotting factor concentrates (CFCs, all in IU):

 

To what degree do all these figures reflect sufficient supply meeting existing needs of the populations? In other words, how much does CONSUMPTION parallel NEEDS? 
 

What are the GAPS / SHORTAGES of the different PDMPs when compared to the real NEEDS?

 

2. Sufficient maturity and level of quality and safety at the Project site:
3. Support by the regulatory and policy regime:
Does a MRA (Medicines Regulatory Authority) exist and function at federal / provincial / local level? Is the applicant institute regularly inspected by a MRA? How can cooperation between the MRA and applicant institute be best described? Is it a constructive and efficient relation?
 
How is the applicant institute supported by policy makers at federal / provincial / local level? How can cooperation between Government / MoH Ministry of Health and the applicant institute be best described? Is it a constructive and efficient?
 
4. Sufficient and constant level of whole blood donations:

Is there an Annual Report available in English for the Blood Programme in the country / province (with figures on whole blood/plasma/cell donations, production of Whole Blood, of blood components: Red Cells, Platelets, Fresh Frozen Plasma, Cryo and Cryo-poor)? (If so, please attach)

 

Is there an Annual Report available in English from the applicant institute (with figures on whole blood/plasma/cell donations, production of Whole Blood, of blood components: Red Cells, Platelets, Fresh Frozen Plasma, Cryo and Cryo-poor)? (If so, please attach) 

What type of donors (whole blood, plasma, platelets) are donating in the country / province / institute?

 

What are the respective percentages of VNRBD, family replacement, paid/compensated in the donor population?

 

5. Committed Focal Point for the Project:

Could applicant institute Management appoint a dedicated contact person at the institute, responsible for coordination of activities, implementation, follow-up, reporting, ... in case a Project is supported by ICSPP?

 

Sign this document digitally by typing your name in the box below.